Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Current Liabilities -----

What is the latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is - based on Mar2025 Consolidated results.
Year Current Liabilities
Mar2025-
Mar2024-
Mar2023-
Mar2022-
Mar2017-

How is Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Current Liabilities % Change
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2017 - -

Compare Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,315.1 Cr -1.8% -4% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,005.0 Cr 2.7% 7.5% 12.8% Stock Analytics
DIVIS LABORATORIES ₹181,867.0 Cr 4.2% 3.9% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹163,246.0 Cr 4.3% 11.2% 42.5% Stock Analytics
CIPLA ₹118,854.0 Cr 0.4% 5.3% -3% Stock Analytics
DR REDDYS LABORATORIES ₹114,246.0 Cr 0.9% 8% 5.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1.8%

-4%

-26.1%

SENSEX

2%

5.3%

-6.5%


You may also like the below Video Courses